Drug | Condition | Dose Range | Drug Dosage | Dose | Volume (ml) |
---|---|---|---|---|---|
Epinephrine (High)
1 mg/ml |
asystole | 0.1-0.2mg/kg IV repeat Q3-5min | |||
Epinephrine (Low)
1 mg/ml |
asystole | 0.01-0.02mg/kg IV repeat Q3-5min | |||
Vassopressin
20 units/ml |
antiarrhythmic | 0.8U/kg IV | |||
Atropine sulfate | bradycardia | 0.02mg/kg IV, IM | |||
Glycopyrrolate
0.2 mg/ml |
bradyarrhythmias | 0.011 mg/kg IV or IM | |||
Calcium gluconate
100 mg/ml |
hypocalcemia | 94-140 mg/kg slow IV | |||
IV Fluids 1x 1x maint |
Maintenance | (30cc x kg) + 70cc IV | |||
IV Fluids 1.5x 1.5x maint |
1.5x Maintenance | (30cc x kg) + 70cc IV x 1.5 | |||
IV Fluids 2x 2x maint |
2x Maintenance | (30cc x kg) + 70cc IV x 2 | |||
IV Fluids Shock Shock |
Shock | 90mL/kg IV | |||
Hetastarch | colloid | 1mL/kg/hr; max 20mL/kg/24hrs | |||
VetStarch 6%
130/0.4 in 0.9% NaCl |
colloid | 20ml/kg, initial 10-20ml slow | |||
Hypertonic Saline
7.2% |
hypovolemic shock | 4 mls/kg single bolus | |||
Dexamethasone
4 mg/ml |
shock | 0.5-3 mg/kg IV | |||
Diazepam
5 mg/ml |
seizure | 0.25mg/kg IV | |||
Dobutamine CRI
12.5 mg/ml |
inotrope | 0.06-0.60mg/kg/hr @ 1 ml/kg/hr | |||
Dopamine CRI
40 mg/ml |
severe hypotension | 0.12-0.60mg/kg/hr@ 1 ml/kg/hr | |||
Doxapram
20 mg/ml |
respiratory stimulant | 5-10mg/kg IV | |||
Lidocaine HCL
20 mg/ml |
antiarrhythmic | 1mg/kg bolus slow IV | |||
Amiodarone
50 mg/ml |
antiarrhythmic | 5mg/kg IV | |||
Mannitol
20% (200mg/ml) |
cerebral edema | 0.5-1.5g/kg IV over 10-20min | |||
Naloxone HCL
0.4 mg/ml |
opioid reversal | 0.01-0.04 mg/kg IV,IM | |||
Flumazenil
0.1 mg/ml |
Benzodiazepine Antagonist | 0.01-0.04 mg/kg IV,IM | |||
Sodium Bicarb
8.2%, 1 mEq/ml |
metabolic acidosis | 1 mEq/kg IV,then 0.5mEq/kg Q15min | |||
Furosemide
50 mg/ml |
Diuretic | 2-8 mg/kg IV or IM | |||
Defibrillator | External Defibrillator | 2-10 Joules/kg | |||
Defibrillator | Internal Defibrillator | 0.2-1.0 Joules/kg |
Naloxone 0.4mg/ml |
Atropine 0.54mg/ml |
Vassopressin 20U/ml |
Epinephrine 1mg/ml |
Lidocaine 20mg/ml |
---|---|---|---|---|